The Screening Gap Nobody Talks About: Why Millions of Women Aren't Getting Cervical Cancer Tests

Cervical cancer screening has cut deaths by more than 50% over the past five decades, yet thousands of women still develop preventable cancer each year because they're not getting tested. The American Cancer Society projects 13,360 new cervical cancer diagnoses and 4,320 deaths in 2025 in the United States alone, despite having highly effective screening tools available. Globally, cervical cancer remains the fourth most common cancer in women, with an estimated 660,000 new cases diagnosed in 2022, largely because screening programs in many countries remain ineffective.

Why Are Screening Rates Still So Low?

The puzzle isn't that cervical cancer screening doesn't work—it absolutely does. The real issue is that certain groups of women face significant barriers to getting tested. Research shows that screening rates vary dramatically depending on where you live, your race, your income, and even your gender identity. Some women are underscreened, meaning they skip regular tests entirely, while others are overscreened, receiving more tests than guidelines recommend. Both patterns indicate that women aren't getting the right screening at the right time.

One major barrier affects women who may not realize they need screening at all. Transgender men and people assigned female at birth who identify as male often have lower Pap test rates than non-transgender women, partly because they may not see themselves as needing cervical cancer screening. Similarly, women with disabilities sometimes face logistical challenges accessing screening services, and LGBTQIA+ individuals report feeling uncomfortable in healthcare settings designed without their needs in mind.

What's Changing in How We Screen for Cervical Cancer?

The good news is that cervical cancer screening is evolving. Instead of relying solely on traditional Pap tests—which look for abnormal cells under a microscope—doctors are increasingly using human papillomavirus (HPV) testing, which detects the virus that actually causes cervical cancer. HPV testing is more accurate at identifying which women are truly at risk, allowing doctors to focus follow-up care on those who need it most.

One breakthrough that could expand access is self-collected HPV testing. Rather than requiring a visit to a clinic where a healthcare provider collects a sample, women can now collect their own samples at home in some cases. Research shows that self-collected samples perform nearly as well as samples collected by a clinician for detecting cervical precancers, opening the door to screening options that fit better into busy lives.

Steps to Getting Appropriate Cervical Cancer Screening

• Know Your Age and Risk Level: The American Cancer Society recommends cervical cancer screening for people with a cervix starting at age 25, with specific intervals depending on which test you receive and your previous results.
• Discuss HPV Testing Options: Talk with your doctor about whether HPV-based screening, traditional Pap testing, or a combination approach makes sense for you, as newer HPV tests offer improved detection capabilities.
• Ask About Self-Collection If Clinic Visits Are Difficult: If scheduling appointments or traveling to a clinic is a barrier, ask your healthcare provider whether self-collected HPV testing is available in your area, as it's becoming more widely offered.
• Understand Your Results: If your screening test shows abnormalities, ask your doctor to explain what the results mean and what follow-up steps are needed, rather than assuming the worst.

Who Is Most Likely to Miss Screening?

Research reveals troubling patterns in who gets screened and who doesn't. Racial disparities persist, with some groups experiencing higher cervical cancer incidence and mortality rates even after accounting for differences in screening access. Women with lower incomes, those without health insurance, and those living in rural areas often face greater obstacles to regular screening. Additionally, women who have had a hysterectomy (surgical removal of the uterus) sometimes incorrectly believe they no longer need cervical cancer screening, even though some may still be at risk depending on the type of surgery they had.

The data shows that ineffective screening programs are directly associated with higher cervical cancer incidence and mortality rates. This isn't because the screening tests themselves fail—it's because the systems designed to deliver those tests aren't reaching everyone who needs them.

What Does the Future of Cervical Cancer Screening Look Like?

Medical organizations are actively working to improve screening access and effectiveness. The U.S. Preventive Services Task Force and the American Society for Colposcopy and Cervical Pathology have updated their guidelines to reflect the latest evidence about HPV testing and risk-based management. These updates aim to reduce unnecessary testing for low-risk women while ensuring that high-risk individuals receive appropriate follow-up care.

New generations of HPV tests are also being developed to improve accuracy and reduce false positives, meaning fewer women will need additional testing when they're actually at low risk. The National Cancer Institute's "Last Mile" initiative specifically focuses on reaching underscreened populations and removing barriers to cervical cancer screening in underserved communities.

The bottom line: cervical cancer is highly preventable when screening reaches the people who need it. If you've been putting off a cervical cancer screening, now is the time to schedule one. Talk with your doctor about which screening approach is right for you, and don't hesitate to ask about options like self-collected testing if traditional clinic visits are difficult to fit into your life.